<DOC>
	<DOCNO>NCT01636895</DOCNO>
	<brief_summary>The study two component : component A cohort study determine vivo efficacy SP clear prevent malaria parasitaemia asymptomatic pregnant woman component B cross sectional study woman deliver study hospital assess effectiveness SP-IPTp reduce adverse maternal birth outcome current context increase SP resistance . Results component A B study use model relationship prevalence molecular marker SP resistance , vivo efficacy clear parasite effectiveness SP-IPTp develop guideline routine monitor effectiveness SP-IPTp part ANC surveillance .</brief_summary>
	<brief_title>Evaluation SP Resistance Effectiveness IPTp Nigeria</brief_title>
	<detailed_description>Study sit include different level transmission social factor affect ANC attendance Damboa hospital Borno state catchment area pop 231,573 semi arid climate malaria mesoendemic . The expected number patient 15-25 per week new booking Park Lane hospital serf semiurban population . Malaria transmission holoendemic stable . 1400 woman attend ANC service per month Women receive SP-IPTp accord National guideline follow 42 day assess therapeutic efficacy parasitaemic woman assess ability remain parasite free . PCR use determine reinfection recrudescence</detailed_description>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>gestational age 1630 week Axillary temperature ,37.5 Degrees inform consent gravida &gt; 2 previous inclusion study history hypersensitivity SP component SP Use IPTp SP pregnancy history take antimalarial past month Known HIV infection</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>malaria</keyword>
	<keyword>pregnancy</keyword>
	<keyword>prevention</keyword>
	<keyword>treatment</keyword>
	<keyword>molecular marker</keyword>
</DOC>